Neuron Therapeutics - Ownership and Business Overview

Medical ProductsCompany

Neuron Therapeutics Ownership

Who owns Neuron Therapeutics?

Neuron Therapeutics is owned by Integra LifeSciences Holdings. It was acquired on September 3, 2003.

Neuron Therapeutics Business Overview

Where is Neuron Therapeutics headquartered?

Neuron Therapeutics is headquartered in Malvern,, Pennsylvania.

What sector is Neuron Therapeutics in?

Neuron Therapeutics is a medical products company.

When was Neuron Therapeutics founded?

Neuron Therapeutics was founded in 1998.

Medical Products M&A Summary in 2003

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2003. The largest medical products acquisition in 2003 was Amersham - which was acquired by General Electric Company for $9.5B.

Join Mergr to view all 53 acquisitions of medical products companies in 2003, including 22 acquisitions by private equity firms, and 31 by strategics.

Neuron Therapeutics, Inc.

81 Great Valley Parkway Great Valley Corporate Center,
Malvern,, Pennsylvania 19355
United States,
(610)578-9494

Neuron Therapeutics was engaged in the development of innovative therapies for the treatment of ischemic disorders of the central nervous system through the application of pharmaceutical and medical device delivery technologies.


 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.